Dr. Steve Webb is a R&D Director responsible for External Technology and Intellectual Property Portfolio Development at Dow AgroSciences. He joined Dow AgroSciences Canada Inc. in 1996 as a Field R&D Scientists in 1996. In 1997, Dr. Webb joined a small team that established the Nexera canola breeding program and was responsible for building the R&D team and the registration of the first Omega-9 canola varieties. Dr. Webb relocated to Indianapolis in 2000 and became Project Success Leader for Animal Health & Nutrition. He led the effort that demonstrated the technical feasibility and registration of the first plant-made vaccines, ARC™ biologics and food safety antibodies. From 2009 to 2013, Dr. Webb led Advanced Technologies Discovery, including the effort to develop and deploy the EXZACT™ Precision Platform Technologies in corn, soybeans, canola and wheat. Dr. Webb represents Dow AgroSciences on several external Boards and Advisory Committees including the Indiana Biosciences Research Institute and Ag-West Bio Inc. He earned his Bachelor of Science in Microbiology from the University of Guelph in 1990. In 1992, he earned his Masters of Science in Biochemistry, followed by a Ph.D. in Immunochemistry in 1998, also from the University of Guelph.